160 related articles for article (PubMed ID: 35968487)
41. Self-administered versus provider-directed sampling in the Anishinaabek Cervical Cancer Screening Study (ACCSS): a qualitative investigation with Canadian First Nations women.
Zehbe I; Wakewich P; King AD; Morrisseau K; Tuck C
BMJ Open; 2017 Sep; 7(8):e017384. PubMed ID: 28864487
[TBL] [Abstract][Full Text] [Related]
42. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
43. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
44. 'It has saved thousands of lives, so why change it?' Content analysis of objections to cervical screening programme changes in Australia.
Obermair HM; Dodd RH; Bonner C; Jansen J; McCaffery K
BMJ Open; 2018 Feb; 8(2):e019171. PubMed ID: 29440214
[TBL] [Abstract][Full Text] [Related]
45. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
47. Co-creation of human papillomavirus self-sampling delivery strategies for cervical cancer screening in rural Zimbabwe: nominal group technique.
Dzobo M; Dzinamarira T; Murewanhema G; Chishapira T; Dube Mandishora RS; Fitzpatrick M; Mashamba-Thompson T
Front Public Health; 2023; 11():1275311. PubMed ID: 38035305
[TBL] [Abstract][Full Text] [Related]
48. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
49. Results from a cervical cancer screening program in Samsun, Turkey.
Arslan HN; Oruc MA
BMC Womens Health; 2022 Aug; 22(1):331. PubMed ID: 35927723
[TBL] [Abstract][Full Text] [Related]
50. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
McCaffery K; Irwig L
J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
[TBL] [Abstract][Full Text] [Related]
51. Self-collecting a cervico-vaginal specimen for cervical cancer screening: an exploratory study of acceptability among medically underserved women in rural Appalachia.
Vanderpool RC; Jones MG; Stradtman LR; Smith JS; Crosby RA
Gynecol Oncol; 2014 Mar; 132 Suppl 1(0 1):S21-5. PubMed ID: 24125753
[TBL] [Abstract][Full Text] [Related]
52. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
Malo TL; Perkins RB; Lee JH; Vadaparampil ST
Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
[TBL] [Abstract][Full Text] [Related]
53. Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening.
Labani S; Asthana S
J Epidemiol Community Health; 2016 Jan; 70(1):72-7. PubMed ID: 26248549
[TBL] [Abstract][Full Text] [Related]
54. Women's perceptions and preferences for cervical cancer screening in light of updated guidelines.
Bustamante G; Liebermann E; McNair K; Fontenot HB
J Am Assoc Nurse Pract; 2023 Nov; 35(11):699-707. PubMed ID: 37498967
[TBL] [Abstract][Full Text] [Related]
55. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
56. Measuring the Preferences of Homeless Women for Cervical Cancer Screening Interventions: Development of a Best-Worst Scaling Survey.
Wittenberg E; Bharel M; Saada A; Santiago E; Bridges JF; Weinreb L
Patient; 2015 Oct; 8(5):455-67. PubMed ID: 25586646
[TBL] [Abstract][Full Text] [Related]
57. Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial.
Spees LP; Des Marais AC; Wheeler SB; Hudgens MG; Doughty S; Brewer NT; Smith JS
Trials; 2019 Dec; 20(1):788. PubMed ID: 31881928
[TBL] [Abstract][Full Text] [Related]
58. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
Racey CS; Gesink DC
J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
[TBL] [Abstract][Full Text] [Related]
59. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
60. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.
Watson M; Benard V; King J; Crawford A; Saraiya M
Prev Med; 2017 Jul; 100():243-247. PubMed ID: 28502575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
